Biodesix® is a lung cancer diagnostic solutions company. Our blood-based tests leverage proteomics and genomics to uncover individualized insights about the tumor biology and the patient's immune response. Biodesix enables our partners throughout the discovery, development and commercialization of personalized diagnostics to support new therapies with companion diagnostic strategies.